Active Ingredient History
Estrogen is a category of sex hormone responsible for the development and regulation of the female reproductive system and secondary sex characteristics. There are three major endogenous estrogens that have estrogenic hormonal activity: estrone (E1), estradiol (E2), and estriol (E3). Estradiol, an estrane, is the most potent and prevalent. Another estrogen called estetrol (E4) is produced only during pregnancy. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alveolar Bone Loss (Phase 3)
Alzheimer Disease (Phase 3)
Amenorrhea (Phase 3)
Angina, Unstable (Phase 3)
Atherosclerosis (Phase 2)
Atrophic Vaginitis (Phase 3)
Atrophy (Phase 3)
Bone Diseases (Phase 3)
Bone Diseases, Metabolic (Phase 3)
Breast Neoplasms (Phase 4)
Cardiovascular Diseases (Phase 3)
Chlamydia Infections (Phase 2)
Colonic Neoplasms (Phase 3)
Contraception (Phase 4)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Depression (Phase 4)
Depressive Disorder, Major (Phase 4)
Diabetes Mellitus (Phase 3)
Endometriosis (Phase 4)
Female Urogenital Diseases (Phase 4)
Fertility (Phase 4)
Fertilization in Vitro (Phase 3)
Fibrosis (Phase 1/Phase 2)
Genetic Diseases, Inborn (Phase 4)
Healthy Volunteers (Phase 2/Phase 3)
Heart Diseases (Phase 3)
Hormones (Phase 2)
Hot Flashes (Phase 4)
Hypercholesterolemia (Phase 3)
Hypertension (Phase 3)
Infertility (Phase 4)
Infertility, Female (Phase 3)
Male (Phase 4)
Memory Disorders (Phase 3)
Menopause (Phase 4)
Migraine Disorders (Phase 1)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 2)
Nocturia (Phase 4)
Osteoporosis (Phase 3)
Ovarian Diseases (Phase 2)
Oxidative Stress (Phase 3)
Pelvic Pain (Phase 4)
Pneumonia, Bacterial (Phase 2)
Polycystic Ovary Syndrome (Phase 4)
Postmenopause (Phase 4)
Pregnancy (Phase 4)
Prostate (Phase 2)
Sleep Apnea, Obstructive (Phase 4)
Sleep Apnea Syndromes (Phase 3)
Stroke (Phase 3)
Thrombosis (Phase 3)
Turner Syndrome (Phase 4)
Urinary Bladder, Overactive (Phase 4)
Urinary Incontinence (Phase 4)
Urinary Tract Infections (Phase 4)
Urination Disorders (Phase 4)
Vaginal Discharge (Phase 4)
Vaginal Diseases (Phase 4)
Vaginosis, Bacterial (Phase 4)
Vaping (Early Phase 1)
Vasomotor System (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
